Tobias Raphael Overbeck

7PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsRadiation therapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 03, 2025
Proteasome inhibition as a potential therapeutic target in thymic cancer.

Satoru Okada, Louisa Benter, Leon Schrell

|Nov 13, 2025
Delay of Systemic Therapy Confers a Survival Benefit in Patients with Stage IV Non-Small-Cell Lung Cancer.

Rike Geiken-Weinstock, Frank Griesinger, Michael Metz

|Jun 19, 2024
Therapeutic Patterns and Clinical Outcomes in Limited Disease Small Cell Lung Cancer: A Decade of Analysis at a Tertiary Cancer Center.

David Alexander Ziegler, Cecilia Christiane Cleve, Sonia Ziegler

|Apr 13, 2024
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.

Oliver Illini, Felix Carl Saalfeld, Petros Christopoulos

|Jan 23, 2024
Outcomes of Multimodal Treatment in Elderly Patients with Localized Non-Small Lung Cancer from a Radiation Oncology Point of View: Special Focus on Low-Dose Cisplatin.

Niklas Josua Alt, Julian Muster, David Alexander Ziegler

|Jan 11, 2024
And Yet It Moves: Clinical Outcomes and Motion Management in Stereotactic Body Radiation Therapy (SBRT) of Centrally Located Non-Small Cell Lung Cancer (NSCLC): Shedding Light on the Internal Organ at Risk Volume (IRV) Concept.

Felix-Nikolai Oschinka Jegor Habermann, Daniela Schmitt, Thomas Failing

Pageof 2

Frequent Collaborators

3 joint publications

Leif Hendrik Dröge

2 joint publications

Achim Rittmeyer

2 joint publications

Hannes Treiber

1 joint publications

Nils Goeken